FDA Clearance Tracker · K213265
Tomey Cornea/Anterior Segment OCT CASIA2
Last checked: Nov 19, 2026Latest source record: Apr 27, 2022 (this decision)Source: openFDAMethods & limitations
Decided
Apr 27, 2022
Substantially Equivalent
Time to decision
209 days
Received Sep 30, 2021. Calendar days, including time FDA spent waiting on the applicant.
Pathway
510(k)
Traditional
Device class
Class II
The decision
- FDA number
- K213265
- Device name
- Tomey Cornea/Anterior Segment OCT CASIA2
- Applicant
- Tomey Corporation
- Applicant location
- Nishi-Ku, JP
- Received
- Sep 30, 2021
- Decided
- Apr 27, 2022
- Decision
- Substantially Equivalent
- Submission type
- Traditional
Device type
- Device type
- Tomography, Optical Coherence (OBO)
- Device class
- Class II
- Regulation
- 21 CFR 886.1570
- Specialty
- Ophthalmology
How new is this?
These are facts about FDA's records. They are not a judgment about the device.
- It is not the first decision under product code OBO. The earliest in FDA's data is K062552, decided Oct 6, 2006.
- It is not on FDA's public list of Breakthrough Devices with marketing authorization (list dated June 30, 2026). FDA does not publish which devices hold the designation before they are authorized, and the list is updated only a few times a year.
Source documents
- FDA database record for K213265
- 510(k) summary (PDF) · FDA posts these some weeks after the decision, so a recent one may not open yet.
The predicate devices this clearance relied on are named in the summary document. We do not extract them yet.
Other decisions for Tomey Corporation
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
K252348 · Decided Dec 18, 2025 · 142 days after receipt
Device type: Device, Analysis, Anterior Segment (MXK) · Ophthalmology
K250553 · Decided Jul 18, 2025 · 143 days after receipt
Device type: Tomography, Optical Coherence (OBO) · Ophthalmology
K171313 · Decided Jan 19, 2018 · 260 days after receipt
Device type: Microscope, Specular (NQE) · Ophthalmology
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.